Overview

Impact of Oral Antibiotic Treatment on C. Difficile

Status:
Completed
Trial end date:
2017-06-27
Target enrollment:
Participant gender:
Summary
The overall aim is to characterize and to compare the extent and quantity of C. difficile stool shedding, perianal colonization and environmental contamination in patients who received oral fidaxomicin, oral metronidazole, or oral vancomycin. This is a prospective, randomized, microbiologic and molecular, study of environmental contamination from patients with proven C. difficile associated diarrhea (CDAD).
Phase:
Phase 4
Details
Lead Sponsor:
Duke University
Treatments:
Amebicides
Anti-Bacterial Agents
Antibiotics, Antitubercular
Fidaxomicin
Metronidazole
Vancomycin